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EH patients and 410 control subjects) and a Uygur population
(371 EH patients and 463 control subjects). Individuals was con-
ducted to identify the association of three SNPs in CYP19 with EH
by using c2 test or ﬁsher exact test. Differences in lipids and
the parameters of echocardiography among individuals with
different genotypes were assessed by using one way analysis of
variance(ANOVA).
RESULTS For women in Han, the distribution of rs2289105 in CYP19
gene showed a signiﬁcant difference between EH and con-
trols(P¼0.049) and the dominant model (CC vsCTþTT) has a signiﬁ-
cant lower risk than the homozygous wild-type CC((p¼0.014), the
dominant model of rs12050772 (GG vsGTþTT) has a signiﬁcant lower
risk in EH patients(p¼0.021). For men in Uygur, the recessive model of
rs4774585 (AA vsAGþGG) has a signiﬁcant higher risk in EH patients
(p¼0.021). ANOVA indicated the left ventricular end-diastolic
dimension is signiﬁcant higher in the homozygous wild-type
(respectively p¼0.001 and P¼0.015).
CONCLUSIONS The T allele of rs2289105 in CYP19 gene might be a
protective genetic marker of EH for women in Han population. The T
allele of rs12050772 in Han population and the A allele of rs4774585 in
Uygur population could be a protective genetic marker, but further
study is needed.GW26-e2201
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OBJECTIVES To explore the optimal time point of recombinant
adeno-associated virus serotype 9-enhanced green ﬂuorescent
protein (rAAV9-eGFP) expression in the aorta of atherosclerosis
mice.
METHODS Atherosclerosis model was established with high-fat diet
in 30 ApoE-/- mice for 16 weeks. Among them, 25 mice were injected
with 5.01011 vg (virus genomes) rAAV9-eGFP through the tail vein,
while the remaining 5 mice were injected with saline, serving as the
control group. The virus-transfected mice were killed at 14, 21, 28,
35 and 60 days after transfection, and aortic tissue was harvested.
The expression of enhanced green ﬂuorescent protein was detected
with laser scanning confocal microscope. Western blot assays were
used to detect the expression of enhanced green ﬂuorescent protein
in aorta. The expression of enhanced green ﬂuorescent protein
in vivo was observed and the optimal expression time point was
determined.
RESULTS rAAV9-eGFP effectively transfected the aorta of athero-
sclerosis mice, enhanced green ﬂuorescent protein was expressed in
aortic tissue, and the expression intensity increased gradually with
the increasing transfection time. The highest expression level was
found at 35 days after transfection and then maintained stable at 60
days. There were signiﬁcant differences at different time points after
transfection (P < 0.05).
CONCLUSIONS rAAV9-eGFP can be effectively expressed in the aorta
of atherosclerosis ApoE-/- mice and rAAV9-eGFP can be regarded as
the optimal vector in the treatment of atherosclerosis.GW26-e4640
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OBJECTIVES Cardiac angiogenesis plays a crucial role in adaptive
hypertrophy in response to pressure overload. We previously showed
that impaired angiogenesis in HSF1 knockout (KO) mice under
increased workload manifested maladaptive hypertrophy and heart
failure. However, the potential mechanism is still incompletely un-
derstood. Here we investigated the function of microRNAs involved inHSF1-dependent angiogenesis and cardiac hypertrophy to pressure
overload.
METHODS Ten weeks old HSF1 KO mice and wild-type (WT)
C57BL/6J mice as control were subjected to transverse aorta
constriction (TAC) for four weeks. Next heart samples from both
groups were performed with microRNAs array analyses based on
the microRNA database release 20. In vitro cultured endothelial
cells were transfected with AMP-activated protein kinase (AMPK)a1
or AMPKa2 plasmids, and then protein levels were determined by
Western blot after mechanical stretch for 24 h. Capillary formation
was analyzed by calculating the numbers of tube-like structures in
whole wells.
RESULTS MicroRNAs array analyses from heart samples revealed
that miR-29, miR-195 and miR-451 were signiﬁcantly upregulated
in HSF1 KO hearts compared with those in WT hearts. We
further conﬁrmed that HSF1 deﬁciency caused a pronounced in-
crease of miR-195 in endothelial cells. Induction of miR-195
signiﬁcantly inhibited AMPKa2 but not affected AMPKa1. Over-
expression of AMPKa2 but not AMPKa1 in endothelial cells,
suppressed p53 activity and enhanced HIF-1a expression in
response to mechanical stretch. AMPKa2 overexpression also
signiﬁcantly increased the level of VEGF and promoted endo-
thelial angiogenesis. Importantly, AMPKa2-mediated p53 suppres-
sion and HIF-1a-dependent angiogenesis were abolished by mimic
transfection of miR-195. Furthermore, we conﬁrmed that HSF1
induction could suppress the enhanced miR-195 level in endo-
thelial cells with mechanical stress, which strengthened the
AMPKa2 expression and attenuated the nuclear accumulation
of p53. In addition, we demonstrated that transfection of
Ad-AMPKa2 in HSF1 KO mice effectively improved cardiac
angiogenesis, reduced cell apoptosis and alleviated myocardial
remodeling in response to TAC.
CONCLUSIONS Our ﬁndings indicate that miR-195 is critically
involved in cardiac remodeling via impairment of HIF-1a-dependent
angiogenesis. Induction of HSF1 might be a novel and effective target
to pressure overload-induced heart failure through regulating the
miR-195/AMPKa2 pathway therapeutically.GW26-e4649
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OBJECTIVES To determine the role of increased late sodium current
in atrial ﬁbrillation (AF) by investigating the effect of sea anemone
toxin-II (ATX-II) on atrial action potential duration (APD) and effec-
tive refractory period (ERP) and the incidence of AF.
METHODS Female New-Zealand rabbit hearts were isolated and
perfused in Langendorff method. Hearts were paced at right
appendage at ﬁxed rate and left atrial and ventricular endo- and epi-
cardial APDs were recorded. Hearts were treated with ATX-II (3 nM)
and paced at right atrium in a programmable mode of S1S2 to create
AF. Ranolazine and TTX at different concentrations were adminis-
tered to hearts with AF in order to observe their effectiveness on
suppressing AF.
RESULTS When hearts were paced at 350 ms, ATX-II (3-15 nM)
signiﬁcantly prolonged atrial MAPD90 by 46  5 ms (n¼6, P <0.001).
In the presence of ATX-II (10-15 nM), spontaneous AF were inves-
tigated in 64.3% (n ¼14) of hearts, but TTX (1mM) and ranolazine (10
mM) terminated AF. When hearts were paced at 440 ms, ranolazine
alone prolonged atrial and ventricular endo- and epi-cardial
MAPD90 by 17  4 ms, 28  5 ms and 23  6 ms (n¼6, p <0.01).
However, in the presence of ATX-II (3 nM), ranolazine shortened
atrial MAPD90 by 33  4 ms (n ¼6, P <0.001). ATX-II (1-3 nM)
increased AF window, AF burden in concentration dependent
manners by 31  11 s and 103  8 ms (n ¼6, P <0.05), respectively.
In the presence of ATX-II (3 nM), ranolazine (3-10 mM) and TTX (0.1-
1 mM) signiﬁcantly reduced AF window and AF burden in concen-
tration dependent manners.
CONCLUSIONS When late sodium current was increased, AF was
induced by prolonging atrial MAPD and ERP, which was the new
mechanism of AF. Both ranolazine and TTX shortened atrial MAPD
and exerted the ability of reducing AF window and AF burden and
preventing AF.
